| Financial Year |
March 31 2023 |
| Monetary Funds |
4,593,810,099.78 |
| Held-for-trading Financial Assets |
343,794,319.55 |
| Notes Receivable |
652,699,394.05 |
| Accounts Receivable |
4,442,570,467.72 |
| Advances to Suppliers |
945,438,213.89 |
| Other Receivables |
385,801,515.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,153,750,521.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
55,599,828.77 |
| Other Current Assets |
439,029,410.50 |
| Total Current Assets |
19,037,593,665.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,323,826,030.33 |
| Investment Properties |
4,131,255,750.73 |
| Fixed Assetes |
4,229,927,505.59 |
| Under-construction Projects |
1,060,328,051.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
747,805,070.61 |
| R&D expenses |
255,265,301.80 |
| Goodwill |
24,123,033.28 |
| Long-Term Deferred and Prepaid Expenses |
186,129,605.38 |
| Deferred Income Tax Assets |
355,408,655.55 |
| Other Non-Current Assets |
230,254,079.00 |
| Sub-Total of Non-Current Assets |
13,429,568,942.47 |
| Total Assets |
32,467,162,607.79 |
| Short-Term Loans |
1,710,106,871.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
901,166,296.55 |
| Accounts Payable |
3,743,165,336.64 |
| Accounts Received In Advance |
18,889,842.52 |
| Employee Compensation Payable |
248,238,287.85 |
| Taxes Payable |
203,465,762.88 |
| Interest Payable |
186,000.00 |
| Dividend Payable |
2,288,255.23 |
| Other payables |
612,765,177.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
250,990,020.89 |
| Other Current Liabilities |
54,936,847.51 |
| Sub-Total of Current Liabilities |
8,337,442,967.84 |
| Long-term Loans |
7,663,559,625.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
602,510,048.61 |
| Special Payable |
-- |
| Estimatied Liabilities |
269,192,085.13 |
| Deferred Income Tax Liabilities |
306,876,436.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,568,369,006.13 |
| Total Liabilities |
17,905,811,973.97 |
| Paid-In Capital(Or Share Stock) |
3,225,799,087.00 |
| Capital Surplus |
4,624,138,599.03 |
| Surplus Reserve |
446,409,205.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,576,652,201.93 |
| Minority Stockholder's Interest |
1,188,587,953.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,372,762,680.10 |
| Owner's Equity（Stockholder's Equity） |
14,561,350,633.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,467,162,607.79 |
